Ultrahuman, a health-intelligence company developing technology to help people better understand and manage their health, announced it has raised $70 million in new financing. According to reports from Business Standard and Entrackr, the funding round was led by Qualcomm Ventures with participation from Labcorp, Alpha Wave, Blume Ventures, Nexus Venture Partners, Alteria and other investors. This financing marks the next chapter in Ultrahuman's evolution from a wearable health company into a human-computer interface company built around the body. Entrackr reports that the company's post-money valuation is estimated at around $363 million, representing a 65% jump from its previous Series B valuation. Ultrahuman had previously raised $35 million in Series B funding and $17.5 million in Series A funding in October 2022.
As reported by Business Standard, Mohit Kumar, founder and CEO of Ultrahuman, explained the company's vision to build an interface that can understand the body continuously and translate its signals into intelligence for everyday life. The platform aims to help people sleep better, understand cardiovascular health, navigate fertility and improve metabolic health, moving beyond traditional dashboards and data collection. Kumar emphasized that the most important computing platform of the next decade will understand the human body continuously across sleep, cardiovascular health, metabolism, hormonal rhythms, blood biomarkers, recovery and environmental factors.
According to the report, the Ultrahuman platform centers around the Ultrahuman Ring, supported by Blood Vision, continuous glucose monitoring, environmental sensing and expanding software, AI and research layers. The Ultrahuman Ring continuously captures physiological signals from the finger, while Blood Vision brings biochemical information across cardiovascular, metabolic, hormonal, inflammatory and longevity markers. M1/M2 Live continuous glucose monitoring adds another layer by capturing metabolic response, with Ultrahuman Home providing insight into the environment where the body sleeps and recovers. The company has also added research initiatives such as Pulsomics, an opt-in platform that allows Ring users to participate in health studies, with current programmes focusing on sleep, VO₂ Max and glucose metabolism.
Ultrahuman reported ₹565 crore in revenue and ₹73 crore profit after tax in FY25, as reported by Entrackr. The company had projected revenue of around ₹1,000 crore for FY26 as it looked to expand further in international markets. The Bengaluru-based company plans to use the capital for product development across sensing, AI, miniaturised electronics, health algorithms, clinical science and research. Ultrahuman was founded by Mohit Kumar and Vatsal Singhal, who sold their logistics startup Runnr to Zomato in 2017.
According to the report, Quinn Li, Senior Vice President of Qualcomm Technologies and global head of Qualcomm Ventures, stated that the future of AI is personal, ambient, and always on, with Ultrahuman pioneering a new generation of personal AI devices. Megann Vaughn Watters, vice president and head of Labcorp Venture Fund and Strategic Alliances, noted that by combining longitudinal wearable data with deeper biological signals, Ultrahuman is creating new opportunities in personalized health. Kumar emphasized that this capital will allow the company to push harder on building the platform and bring what they build to millions of people around the world.
